Levi Strauss Valuation
Is LEVI * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of LEVI * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: LEVI * (MX$328) is trading above our estimate of fair value (MX$314.11)
Significantly Below Fair Value: LEVI * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for LEVI *?
Other financial metrics that can be useful for relative valuation.
| What is LEVI *'s n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | US$8.45b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.7x |
| Enterprise Value/EBITDA | 14.9x |
| PEG Ratio | 1.8x |
Price to Earnings Ratio vs Peers
How does LEVI *'s PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 12.2x | ||
TPR Tapestry | 9.9x | 7.4% | US$9.2b |
UHR Swatch Group | 11.6x | 2.7% | CHF10.0b |
PVH PVH | 9.5x | 6.8% | US$6.3b |
RL Ralph Lauren | 17.8x | 7.8% | US$10.5b |
LEVI * Levi Strauss | 67.9x | 37.3% | Mex$8.4b |
Price-To-Earnings vs Peers: LEVI * is expensive based on its Price-To-Earnings Ratio (67.9x) compared to the peer average (12.2x).
Price to Earnings Ratio vs Industry
How does LEVI *'s PE Ratio compare vs other companies in the Global Luxury Industry?
Price-To-Earnings vs Industry: LEVI * is expensive based on its Price-To-Earnings Ratio (67.9x) compared to the Global Luxury industry average (19.4x).
Price to Earnings Ratio vs Fair Ratio
What is LEVI *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 67.9x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate LEVI *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | n/a | Mex$374.16 0% | 8.6% | Mex$425.50 | Mex$323.38 | n/a | 14 |
| Apr ’25 | Mex$343.99 | Mex$301.79 -12.3% | 12.7% | Mex$382.36 | Mex$232.74 | n/a | 14 |
| Mar ’25 | n/a | Mex$299.73 0% | 12.2% | Mex$392.09 | Mex$238.67 | n/a | 14 |
| Feb ’25 | Mex$271.00 | Mex$297.87 +9.9% | 11.6% | Mex$394.47 | Mex$240.11 | n/a | 14 |
| Jan ’25 | Mex$274.45 | Mex$280.60 +2.2% | 14.1% | Mex$356.63 | Mex$220.77 | n/a | 13 |
| Dec ’24 | Mex$261.00 | Mex$277.80 +6.4% | 13.8% | Mex$359.77 | Mex$222.72 | n/a | 13 |
| Nov ’24 | Mex$244.00 | Mex$297.08 +21.8% | 13.8% | Mex$384.74 | Mex$238.17 | n/a | 13 |
| Oct ’24 | Mex$230.00 | Mex$288.92 +25.6% | 12.5% | Mex$371.35 | Mex$247.57 | n/a | 13 |
| Sep ’24 | Mex$236.00 | Mex$275.45 +16.7% | 14.0% | Mex$368.38 | Mex$234.42 | n/a | 12 |
| Aug ’24 | Mex$259.00 | Mex$275.45 +6.3% | 14.0% | Mex$368.38 | Mex$234.42 | n/a | 12 |
| Jul ’24 | Mex$246.00 | Mex$312.43 +27.0% | 14.3% | Mex$410.87 | Mex$256.79 | n/a | 12 |
| Jun ’24 | n/a | Mex$337.59 0% | 12.7% | Mex$435.99 | Mex$272.49 | n/a | 12 |
| May ’24 | Mex$266.00 | Mex$337.59 +26.9% | 12.7% | Mex$435.99 | Mex$272.49 | n/a | 12 |
| Apr ’24 | n/a | Mex$345.43 0% | 12.8% | Mex$432.54 | Mex$288.36 | Mex$343.99 | 12 |
| Mar ’24 | n/a | Mex$360.96 0% | 12.7% | Mex$446.90 | Mex$297.94 | n/a | 13 |
| Feb ’24 | Mex$336.27 | Mex$360.96 +7.3% | 12.7% | Mex$446.90 | Mex$297.94 | Mex$271.00 | 13 |
| Jan ’24 | Mex$300.00 | Mex$391.69 +30.6% | 14.8% | Mex$530.41 | Mex$314.32 | Mex$274.45 | 13 |
| Dec ’23 | Mex$311.55 | Mex$386.46 +24.0% | 14.2% | Mex$519.33 | Mex$307.75 | Mex$261.00 | 13 |
| Nov ’23 | Mex$304.00 | Mex$402.23 +32.3% | 14.1% | Mex$538.46 | Mex$319.09 | Mex$244.00 | 13 |
| Oct ’23 | Mex$328.51 | Mex$507.65 +54.5% | 16.2% | Mex$664.57 | Mex$382.63 | Mex$230.00 | 13 |
| Sep ’23 | n/a | Mex$502.06 0% | 16.0% | Mex$657.26 | Mex$378.42 | Mex$236.00 | 13 |
| Aug ’23 | n/a | Mex$524.33 0% | 16.0% | Mex$682.04 | Mex$392.69 | Mex$259.00 | 13 |
| Jul ’23 | Mex$327.00 | Mex$578.62 +76.9% | 16.2% | Mex$781.92 | Mex$449.60 | Mex$246.00 | 13 |
| Jun ’23 | Mex$356.00 | Mex$599.51 +68.4% | 15.7% | Mex$801.81 | Mex$461.04 | n/a | 13 |
| May ’23 | Mex$375.00 | Mex$622.69 +66.1% | 13.7% | Mex$815.61 | Mex$509.76 | Mex$266.00 | 13 |
Analyst Forecast: Target price is less than 20% higher than the current share price.